The Future of Pharma Across All Sectors in the Artificial Intelligence Era
暫譯: 人工智慧時代下各領域製藥的未來

Lytras, Miltiadis, Shaman, Ahmed M., de Pablos, Patricia Ordonez

  • 出版商: Academic Press
  • 出版日期: 2026-08-21
  • 售價: $6,080
  • 貴賓價: 9.5$5,776
  • 語言: 英文
  • 頁數: 476
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 0443405727
  • ISBN-13: 9780443405723
  • 相關分類: Machine Learning區塊鏈 Blockchain
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

The Future of Pharma Across All Sectors in the Artificial Intelligence Era offers a thorough examination of the pharmaceutical industry's current landscape, highlighting the myriad challenges, opportunities, and trends that are poised to shape its future. Edited by experts, this book delves into transformative technological advancements, including artificial intelligence, machine learning, big data analytics, and blockchain. These technologies are redefining pharmaceutical research, development, and commercialization, making precision medicine and personalized therapies a reality, while integrating genomic medicine into the pharmaceutical value chain.

Additionally, the book addresses educational implications for academic curricula, emphasizing the need for digital transformation in healthcare delivery models. It scrutinizes regulatory trends and compliance, offering insights into navigating complex landscapes to ensure product quality and safety. The book emphasizes the pharmaceutical industry's role in tackling infectious diseases and health disparities, promoting health equity through innovative drug development and access initiatives. Future trends and predictions are speculated upon, considering demographic shifts and evolving healthcare needs, while market dynamics and commercial strategies are analyzed to equip pharmaceutical companies with practical recommendations for navigating competitive landscapes.

商品描述(中文翻譯)

《人工智慧時代的製藥未來》提供了對製藥行業當前狀況的深入探討,突顯出許多挑戰、機會和趨勢,這些因素將塑造其未來。本書由專家編輯,深入探討了變革性的技術進步,包括人工智慧、機器學習、大數據分析和區塊鏈。這些技術正在重新定義製藥的研究、開發和商業化,使精準醫療和個性化療法成為現實,同時將基因醫學整合進製藥價值鏈中。

此外,本書還探討了對學術課程的教育影響,強調在醫療服務模式中數位轉型的必要性。它審視了監管趨勢和合規性,提供了在複雜環境中導航的見解,以確保產品質量和安全性。本書強調製藥行業在應對傳染病和健康差距方面的角色,通過創新的藥物開發和獲取計劃促進健康公平。未來的趨勢和預測也被提出,考慮到人口變遷和不斷演變的醫療需求,同時分析市場動態和商業策略,以為製藥公司提供實用建議,幫助其在競爭激烈的環境中導航。